Pharmaceutical Supply – Glucagon for Injection

The contract entails the manufacture and supply of a single unit of Glucagon for Injection identified by NSN 6505014667505, destined for use aboard a U.S. Navy submarine. The product must comply fully with all FDA regulatory requirements and federal procurement standards to ensure safety, efficacy, and reliability in a military operational environment. This is a subcontract under the auspices of the Defense Logistics Agency, part of the Department of Defense, with the North American Industry Classification System code 325412 indicating pharmaceutical preparation manufacturing as the relevant industry classification. Delivery is specified to meet the unique logistical and operational demands of naval submarine missions, though no specific delivery location beyond the U.S. Navy submarine context is detailed. The contract was posted on July 15, 2026, and is linked to the award record SPE2DX25D8022 with delivery reference SPE2D926F7356, indicating its integration into the broader defense supply chain managed through DLA’s procurement systems.